Patrick Michl

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 19

Top Venues

Cancers

JMIR research protocols

Journal of clinical medicine

Gut

Martin-Luther-Universität Halle-Wittenberg

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Martin-Luther-Universität Halle-Wittenberg Mar 01 2015

Germany

Director :: Dept. of Internal Medicine I

Publications

Patrick Michl, Laura Roth
Female advantage in neoadjuvant pancreatic cancer therapy: is it down to macrophages? Gut (2023)
Patrick Michl, Sebastian Krug
Targeting myeloid signalling pathways to unleash T cells. Gut (2023)
Sophia Stahl-Toyota, Christoph Nikendei, Ede Nagy, Stefan Bönsel, Ivo Rollmann, Inga Unger, Julia Szendrödi, Norbert Frey, Patrick Michl, Carsten Müller-Tidow, Dirk Jäger, Hans Christoph Friederich, Achim Hochlehnert
Interaction of mental comorbidity and physical multimorbidity predicts length-of-stay in medical inpatients. PloS one 18 (6) (2023)
Maren Juliane Egidi, Sebastian Krug, Johannes Haybaeck, Patrick Michl, Heidi Griesmann
Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis. British journal of cancer (2023)
Artur Rebelo, Ulrich Ronellenfitsch, Jumber Partsakhashvili, Endres John, Carsten Sekulla, Sebastian Krug, Jonas Rosendahl, Patrick Michl, Joerg Ukkat, Jorg Kleeff
Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective Study. JMIR research protocols 11 (12) (2022)
Artur Rebelo, Ulrich Ronellenfitsch, Jumber Partsakhashvili, Endres John, Carsten Sekulla, Sebastian Krug, Jonas Rosendahl, Patrick Michl, Joerg Ukkat, Jorg Kleeff
Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective Study. JMIR research protocols 11 (12) (2022)
Sebastian Krug, Maryam Khosravian, Julia Weissbach, Katharina George, Marko Damm, Jakob Garbe, Jens Walldorf, Philipp Alexander Reuken, Tania Amin, Alexander Reinhard Siebenhüner, Jonas Rosendahl, Thomas Matthias Gress, Patrick Michl, Jörg Schrader, Anja Rinke
The Patient's Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers 14 (3) (2022)
Florian Sperling, Danny Misiak, Stefan Hüttelmaier, Patrick Michl, Heidi Griesmann
IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2. Cancers 14 (9) (2022)
Sally Kfoury, Patrick Michl, Laura Roth
Modeling Obesity-Driven Pancreatic Carcinogenesis-A Review of Current In Vivo and In Vitro Models of Obesity and Pancreatic Carcinogenesis. Cells 11 (19) (2022)
Artur Rebelo, Ulrich Ronellenfitsch, Jumber Partsakhashvili, Endres John, Carsten Sekulla, Sebastian Krug, Jonas Rosendahl, Patrick Michl, Joerg Ukkat, Jorg Kleeff
Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective Study. JMIR research protocols 11 (12) (2022)
Artur Rebelo, Ulrich Ronellenfitsch, Jumber Partsakhashvili, Endres John, Carsten Sekulla, Sebastian Krug, Jonas Rosendahl, Patrick Michl, Joerg Ukkat, Jorg Kleeff
Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective Study. JMIR research protocols 11 (12) (2022)
Patrick Michl, Johannes Matthias Löhr, John P Neoptolemos, Gabriele Capurso, Vinciane Rebours, Núria Malats, Mathilde Ollivier, Luigi Ricciardiello
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better. United European gastroenterology journal (2021)
Heidi Griesmann, Sebastian Mühl, Jan Riedel, Katharina Theuerkorn, Bence Sipos, Irene Esposito, Gregory B Vanden Heuvel, Patrick Michl
CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation. Cancers 13 (10) (2021)
Sebastian Krug, Marko Damm, Jakob Garbe, Senta König, Rosa Lynn Schmitz, Patrick Michl, Jörg Schrader, Anja Rinke
Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality. Journal of clinical medicine 10 (14) (2021)
Marko Damm, Ljupcho Efremov, Benedikt Birnbach, Gretel Terrero, Jorg Kleeff, Rafael Mikolajczyk, Jonas Rosendahl, Patrick Michl, Sebastian Krug
Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer-A Systematic Review and Meta-Analysis. Cancers 13 (17) (2021)
Rosa Lynn Schmitz, Julia Weissbach, Jan Kleilein, Jessica Bell, Stefan Hüttelmaier, Fabrice Viol, Till Sebastian Clauditz, Patricia Grabowski, Helmut Laumen, Jonas Rosendahl, Patrick Michl, Jörg Schrader, Sebastian Krug
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models. Cells 10 (6) (2021)
Diana Oelschlaegel, Tommy Weiss Sadan, Seth Salpeter, Sebastian Krug, Galia Blum, Werner Schmitz, Almut Schulze, Patrick Michl
Cathepsin Inhibition Modulates Metabolism and Polarization of Tumor-Associated Macrophages. Cancers 12 (9) (2020)
Sebastian Krug, Jakob Garbe, Senta König, Hanna Ungewiss, Patrick Michl, Anja Rinke, Jörg Schrader
Professional Assessment of the Impact of COVID-19 on Handling NET Patients. Journal of clinical medicine 9 (11) (2020)
Soeren M Buchholz, Robert G Goetze, Shiv K Singh, Christoph Ammer-Herrmenau, Frances M Richards, Duncan I Jodrell, Malte Buchholz, Patrick Michl, Volker Ellenrieder, Elisabeth Hessmann, Albrecht Neesse
Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer. Cancers 12 (7) (2020)

Patrick Michl.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Patrick Michl